AGL
Income statement / Annual
Last year (2024), agilon health, inc.'s total revenue was $6.06 B,
an increase of 40.41% from the previous year.
In 2024, agilon health, inc.'s net income was -$260.10 M.
See agilon health, inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$6.06 B |
$4.32 B |
$2.71 B |
$1.83 B |
$1.22 B |
$794.41 M |
| Cost of Revenue |
$6.06 B
|
$4.25 B
|
$2.60 B
|
$1.76 B
|
$1.12 B
|
$765.90 M
|
| Gross Profit |
$4.84 M
|
$69.67 M
|
$112.29 M
|
$76.41 M
|
$94.15 M
|
$28.51 M
|
| Gross Profit Ratio |
0
|
0.02
|
0.04
|
0.04
|
0.08
|
0.04
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$268.91 M
|
$285.76 M
|
$218.95 M
|
$455.82 M
|
$137.29 M
|
$122.83 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$268.91 M
|
$285.76 M
|
$218.95 M
|
$455.82 M
|
$137.29 M
|
$122.83 M
|
| Other Expenses |
$28.06 M
|
$16.04 M
|
$24.73 M
|
$14.54 M
|
$13.53 M
|
$12.25 M
|
| Operating Expenses |
$296.97 M
|
$301.80 M
|
$218.95 M
|
$470.37 M
|
$150.82 M
|
$135.09 M
|
| Cost And Expenses |
$6.35 B
|
$4.55 B
|
$218.95 M
|
$2.23 B
|
$1.28 B
|
$900.99 M
|
| Interest Income |
$0.00
|
$0.00
|
$4.53 M
|
$6.15 M
|
$8.14 M
|
$9.07 M
|
| Interest Expense |
$6.18 M
|
$6.66 M
|
$4.48 M
|
$6.15 M
|
$8.14 M
|
$9.07 M
|
| Depreciation & Amortization |
$24.46 M
|
$20.16 M
|
$13.77 M
|
$14.67 M
|
$14.10 M
|
$41.41 M
|
| EBITDA |
-$218.19 M |
-$167.64 M |
-$72.41 M |
-$383.78 M |
-$40.11 M |
-$64.21 M |
| EBITDA Ratio |
-0.04
|
-0.04
|
-0.04
|
-0.21
|
-0.03
|
-0.08
|
| Operating Income Ratio |
-0.05
|
-0.05
|
-0.04
|
-0.21
|
-0.05
|
-0.13
|
| Total Other Income/Expenses Net |
$43.30 M
|
$37.67 M
|
$14.71 M
|
-$32.36 M
|
-$5.67 M
|
-$8.11 M
|
| Income Before Tax |
-$248.83 M
|
-$194.46 M
|
-$105.69 M
|
-$404.60 M
|
-$62.34 M
|
-$114.69 M
|
| Income Before Tax Ratio |
-0.04
|
-0.05
|
-0.04
|
-0.22
|
-0.05
|
-0.14
|
| Income Tax Expense |
$1.45 M
|
$791,000.00
|
$1.18 M
|
$886,000.00
|
$865,000.00
|
-$232,000.00
|
| Net Income |
-$260.10 M
|
-$262.60 M
|
-$106.86 M
|
-$405.48 M
|
-$63.21 M
|
-$114.46 M
|
| Net Income Ratio |
-0.04
|
-0.06
|
-0.04
|
-0.22
|
-0.05
|
-0.14
|
| EPS |
-0.63 |
-0.64 |
-0.26 |
-1.01 |
-0.16 |
-0.29 |
| EPS Diluted |
-0.63 |
-0.64 |
-0.26 |
-1.01 |
-0.16 |
-0.29 |
| Weighted Average Shares Out |
$410.97 M
|
$408.92 M
|
$408.15 M
|
$400.10 M
|
$390.83 M
|
$390.83 M
|
| Weighted Average Shares Out Diluted |
$410.97 M
|
$408.92 M
|
$408.15 M
|
$400.10 M
|
$390.83 M
|
$390.83 M
|
| Link |
|
|
|
|
|
|
